A new study has found that – no surprise at all – antipsychotics are associated with a much higher death rate for people with dementia. After looking at death rates for people with dementia who were given an antipsychotic compared to a matched cohort of people with dementia who were not given antipsychotics, the authors found significant mortality risks.
- For Zyprexa, the risk of death for people with dementia within 180 days was 46% higher;
- For Seroquel, the risk of death was 31% higher;
- For Risperdal, the risk of death was 68% higher;
- For Haldol, the risk of death was a whopping 150% higher.
For people who have only loosely followed the issue of antipsychotics as a “treatment” for dementia, the increased mortality associated with these drugs is well-known. However, the new study also looked at Depakote, an anti-seizure drug that is often misused as a chemical restraint for people with dementia. Depakote misuse has largely been ignored by the national and statewide movements to end chemical restraints in nursing homes. The study found a very troubling 62% increase in mortality for people with dementia who are given Depakote for 180 days.